Drug-labels.com

Taro-Calcitriol: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
0.25 mcg, 0.5 mcg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Taro-Calcitriol

ABOUT THIS MEDICATION

you are undergoing dialysis.

you have a history of heart disease.

you are using cardic glycosides (e.g.digitalis). you are pregnant or planning to become pregnant during treatment.

you are breastfeeding or planning to breastfeed. Taro-Calcitriol may be released in human breast milk. Discuss with your doctor.

you are taking any other drugs including non- prescription drugs, other vitamin D products, or other forms of vitamin D or any other vitamins or supplements.

What the medication is used for:

Taro-Calcitriol is indicated in the management of

Calcium deficiency (hypocalcemia) and bone disease in patients with chronic renal failure undergoing dialysis Calcium deficiency (hypocalcemia) in patients with hypoparathyroidism (underactive parathyroid glands). Rickets (type of bone disease).

What it does:

Taro-Calcitriol helps patients with kidney or bone disease (e.g. rickets) who cannot make enough of the active form of vitamin D in the body to meet their needs. Taro-Calcitriol supplies this form of vitamin D which the body can use to meet requirements.

When it should not be used:

If you are allergic to the medicinal ingredient calcitrol, vitamin D, other vitamin D products or other forms of vitamin D or to any of the nonmedicinal ingredients in this formulation (see What the non-medicinal ingredients are).

If you have hypercalcemia (high levels of calcium in the blood).

What the medicinal ingredient is:

Calcitriol

What the important non-medicinal ingredients are: Butylhydroxyanisole, butylhydroxytoluene, medium-chain triglycerides, gelatin, liquid sorbitol, glycerol, methyl paraben, propyl paraben, ferric oxide (red), ferric oxide (yellow) in 0.25 mcg strength only, titanium dioxide, triethyl citrate, shellac glaze, iron oxide black, propylene glycol and ammonium hydroxide.

What dosage forms it comes in:

Capsules 0.25 mcg: Peach colored, oval, soft gelatin capsule imprinted with '967' in black ink, containing clear, colorless to slightly yellowish oily liquid.

Capsules 0.50 mcg: Brown colored, oval, soft gelatin capsule imprinted with '968' in black ink, containing clear, colorless to slightly yellowish oily liquid.

WARNINGS AND PRECAUTIONS

BEFORE you use Taro-Calcitriol talk to your doctor or pharmacist if:

you are allergic to vitamin D or other forms of vitamin D products or to any ingredient of Taro-Calcitriol. you have a history of kidney disease.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with Taro-Calcitriol include: digitalis, bile acid sequestrants (including cholestyramine and sevelamer) and mineral oil, anticonvulsants (e.g. phenytoin, phenobarbital), calcium supplements, corticosteroids, ketoconazole, magnesium- containing drugs (e.g. some antacids), thiazides.

PROPER USE OF THIS MEDICATION

The effectiveness of Taro-Calcitriol therapy is based on the assumption that each patient is receiving an adequate daily intake of calcium.

To ensure that you receive an adequate daily intake of calcium, your doctor may either prescribe a calcium supplement or instruct appropriate dietary measures. Your doctor may monitor your blood levels of calcium and phosphorus.

Be sure to drink plenty of fluids to maintain good hydration, important during Taro-Calcitriol treatment.

Usual adult dose:

Dosage is based on your medical condition and response to therapy. Your doctor may start you on a low dose and adjust the dose slowly to find the best dose for you. Follow your doctor's directions carefully.

Missed Dose

Take you missed dose as soon as you remember. Skip taking the missed dose if it is almost time for the next scheduled dose. No extra medicine should be taken to make up the missed dose.

Overdose:

If you think you have taken too much Taro-Calcitriol, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effect of Taro-Calcitriol is hypercalcemia -high calcium levels in the blood (see Serious Side Effects table below for symptoms). Common side effects include nausea, vomiting, stomach cramps, itching and sleeplessness.

Other side effects include agitation, sleeplessness, lack of feeling, weakness, constipation, upper abdominal pain, redness or itching

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and call your
Common

Headache

Abdominal pain - Rash

Urinary tract

infection

√
UncommonDecreased appetite Vomiting√
Not known

Allergic reactions - Possible

symptoms:

hives, difficulty breathing, swelling of your face, lips, tongue, or throat.

Difficulty in

understanding

Growth retardation Excessive urination Calcium deposits on the skin

Weight loss

√√
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and call your doctor or pharmacist
Only if severeIn all cases

Very

common

Higher blood

calcium levels than normal.

Possible

symptoms:

Early symptoms: weakness,

headache,

drowsiness,

nausea, irregular heartbeat,

excessive thirst, vomiting, dry

mouth,

constipation,

muscle pain, bone pain, metallic taste, abdominal pain or stomach ache.

Late symptoms: frequent urination (including needing to urinate at night), excessive thirst, urinary tract

infections,

anorexia, weight loss, conjunctivitis, inflammation of the pancreas,

sensitivity to light, runny nose,

itching, feeling feverish, decreased sex drive, too

much protein in the urine, high

cholesterol,

elevated liver

function tests,

excessive calcium in tissues, high blood pressure, irregular heartbeat, and rarely, loss of contact with

reality.

√

of the skin, excessive thirst, fever and joint pain. If these side effects become bothersome or persist, contact your doctor.

This is not a complete list of side effects. For any unexpected effects while taking, Taro-Calcitriol contact your doctor or pharmacist.

HOW TO STORE IT

Capsules should be stored a 15-25 C. Store in the original container. Protect from light and moisture. Keep blister in the outer carton. Keep out of sight and reach of children.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting

    (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about Taro-Calcitriol:

  • Talk to your healthcare professional
  • Find the full Product Monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada.html); the manufacturer’s website www.taro.ca, or by calling 1-800-268-1975.

Taro Pharmaceuticals Inc.

130 East Drive

Brampton, Ontario L6T 1C1

TARO is a registered trademark of Taro Pharmaceuticals Inc.

Date Prepared: February 11, 2019

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02485710

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Taro-Calcitriol

Rx or OTC
Prescription (Rx)?
DIN 02485710, 02485729
Schedule(s) PRESCRIPTION
Active ingredient(s) Calcitriol
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A11 Vitamins
      1. A11C Vitamin A and D, incl. combinations of the two
        1. A11CC Vitamin D and analogues
          1. A11CC04 Calcitriol
Company TARO PHARMACEUTICALS INC
Current status Marketed
Current status date June 3, 2019
Strengths and forms
DIN Strength Dosage form(s) Current status
02485710 0.25 MCG Capsule Marketed June 3, 2019
02485729 0.5 MCG Capsule Marketed June 3, 2019

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.